Sysmex-derived COVID-19 prognostic score as an early prognostic marker for severity of the COVID-19 disease

Martin Blažek1,2, Filip Vrbacký3, Ilona Fátorová3

  • 1Pulmonary Clinic, University Hospital Hradec Králové, Hradec Králové, Czech Republic.

Insights

The COVID-19 prognostic score effectively predicts severe disease in patients with Coronavirus disease 2019 (COVID-19). This accessible marker aids early risk stratification and timely intervention for better patient outcomes.

Area of Science:

  • Infectious Diseases
  • Clinical Medicine
  • Biomarkers

Background:

  • Coronavirus disease 2019 (COVID-19) presents a heterogeneous clinical course, with some young patients experiencing severe outcomes.
  • Identifying early, accessible markers to predict COVID-19 severity is crucial for clinical management.
  • The COVID-19 prognostic score offers a potential tool for early risk assessment.

Purpose of the Study:

  • To evaluate the COVID-19 prognostic score as a predictor of disease severity.
  • To assess the clinical utility of the prognostic score in patients with confirmed SARS-CoV-2 infection.
  • To determine the score's ability to stratify patients at high risk for severe COVID-19.

Main Methods:

  • The COVID-19 prognostic score and laboratory parameters were assessed in patients with respiratory tract infections and positive SARS-CoV-2 PCR tests.
  • Prognostic significance was determined using receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis.
  • Blood count, hemostasis, and biochemical indicators were analyzed.

Main Results:

  • The COVID-19 prognostic score demonstrated a high AUC of 0.855, indicating strong predictive value.
  • A threshold of 1.5 on the score achieved high sensitivity (91.9%) and specificity (71.7%) for identifying severe disease.
  • The predictive value of a negative test result was also significant (0.968).

Conclusions:

  • The COVID-19 prognostic score is a promising indicator for stratifying patients.
  • It enables timely identification of high-risk individuals at the initial point of care.
  • This facilitates prompt escalation of care for patients at risk of severe COVID-19 development.
Abstract